Detalhe da pesquisa
1.
A phase 1/2 study of pepinemab in children, adolescents, or young adults with recurrent or refractory solid tumors: A children's oncology group consortium report (ADVL1614).
Pediatr Blood Cancer
; 71(6): e30938, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520670
2.
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors.
Pediatr Blood Cancer
; 71(3): e30817, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189770
3.
Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.
Cancer
; 129(14): 2245-2255, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081608
4.
Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.
Pediatr Blood Cancer
; 70 Suppl 6: e30563, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37430453
5.
Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
Pediatr Blood Cancer
; 70(12): e30672, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710306
6.
Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1).
Pediatr Blood Cancer
; 70(11): e30609, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37553297
7.
Guidelines for the Neurocritical Care Management of Aneurysmal Subarachnoid Hemorrhage.
Neurocrit Care
; 39(1): 1-28, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202712
8.
Exploring young Australians' understanding of sustainable and healthy diets: a qualitative study.
Public Health Nutr
; : 1-13, 2022 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35796027
9.
Drivers of food choice among women living in informal settlements in Nairobi, Kenya.
Appetite
; 168: 105748, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637773
10.
Care of the Patient With Acute Ischemic Stroke (Endovascular/Intensive Care Unit-Postinterventional Therapy): Update to 2009 Comprehensive Nursing Care Scientific Statement: A Scientific Statement From the American Heart Association.
Stroke
; 52(5): e198-e210, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691467
11.
A phase 1 study of prexasertib (LY2606368), a CHK1/2 inhibitor, in pediatric patients with recurrent or refractory solid tumors, including CNS tumors: A report from the Children's Oncology Group Pediatric Early Phase Clinical Trials Network (ADVL1515).
Pediatr Blood Cancer
; 68(9): e29065, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881209
12.
A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1513, Pediatric Early Phase-Clinical Trial Network (PEP-CTN).
Pediatr Blood Cancer
; 68(4): e28892, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33438318
13.
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors.
Pediatr Blood Cancer
; 68(11): e29282, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34383370
14.
A focused ethnographic study on the role of health and sustainability in food choice decisions.
Appetite
; 165: 105319, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34004242
15.
Derivation and Demonstration of a New Metric for Multitasking Performance.
Hum Factors
; 63(5): 833-853, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33030381
16.
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(4): 541-550, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32192573
17.
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.
Lancet Oncol
; 21(1): 121-133, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31812554
18.
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials.
Lancet Oncol
; 21(2): 271-282, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838007
19.
ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study.
Cancer
; 126(24): 5303-5310, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32914879
20.
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma.
Pediatr Blood Cancer
; 67(1): e28031, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31612589